Metronomic oral cyclosphosphamide as 3rd line systemic...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

Metronomic oral cyclosphosphamide as 3rd line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma

Lee, V.H., Kwong, D.W., Lai, Y-C., Li, Y., Lam, K-O., Ho, P.Y.P., Chan, W-L., Wong, L-S., Leung, D.K., Chan, S-Y., Chan, F-T., Lau, K-S., Tse, R.P., Leung, T-W., Lee, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw376.34
Date:
October, 2016
File:
PDF, 32 KB
english, 2016
Conversion to is in progress
Conversion to is failed